Loading
Latest filing published 12 Aug 2026 for Avalo Therapeutics, Inc., €45k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by Jennifer Riley on record concern Avalo Therapeutics, Inc. Over a trading history stretching from 10 December 2025 to 11 August 2026, the count stands at 4 filings.
On the market, this insider has only sold: 1 sale, €45k in total. The rest of the record consists of 3 share grants. 2026 to date brings no purchases and 1 sale.
Most recently, on 12 August 2026, the filings show an open-market sale worth €45k in Avalo Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations